How well does Sandostatin(Octreotide Acetate Injection) work?

BYNFEZIA PEN (octreotide acetate) is a somatostatin analog used to manage hormone-secreting conditions by reducing growth hormone and vasoactive peptide levels, thereby alleviating associated symptoms in specific neuroendocrine disorders.

Therapeutic Applications of BYNFEZIA PEN in Hormone-Related Disorders

BYNFEZIA PEN demonstrates therapeutic efficacy through its inhibitory action on excessive hormone secretion in acromegaly, metastatic carcinoid tumors, and vasoactive intestinal peptide-secreting tumors (VIPomas). In acromegaly, it lowers circulating levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1), providing symptomatic relief when conventional treatments such as surgery, radiation, or bromocriptine fail. In carcinoid syndrome, it mitigates symptoms like severe diarrhea and flushing by inhibiting bioactive peptide release. Similarly, for VIPomas, it addresses profuse watery diarrhea by suppressing excessive VIP production. The drug’s clinical utility lies in its role as a symptomatic and biochemical control agent, although its impact on tumor regression was not demonstrated in trials.